Working Together to Combat Antibiotic Resistance

Working Together to Combat Antibiotic Resistance

Today, the White House convened its first ever Forum on Antibiotic Stewardship, bringing together more than 150 organizations committed to combatting the threat of antibiotic resistance. Pew was honored to participate in this event, which included leaders from the public health, health care, pharmaceutical, agriculture, and food retail sectors whose work focuses on human and animal health.

Throughout the day, participating organizations announced commitments to various efforts aimed at slowing the emergence of antibiotic-resistant bacteria, detecting resistant strains, preserving the efficacy of our existing antibiotics, and preventing the spread of resistant infections. To this end, Pew announced a new partnership with the Centers for Disease Control and Prevention (CDC) to develop concrete national goals for reducing inappropriate antibiotic use. These efforts, which will involve a broad coalition of stakeholders, are intended to complement President Obama’s Combating Antibiotic-Resistant Bacteria (CARB) strategy and ensure that reductions in antibiotic use are achieved.

With approximately 2 million people acquiring serious antibiotic-resistant infections, and 23,000 dying as a result each year, it is vital that hospitals and doctors use antibiotics judiciously and preserve these life-saving treatments for patients truly in need. Pew’s partnership with the CDC is an important step in that direction.

However, antibiotic stewardship is only one part of the solution. Discovering and developing new antibiotics is essential to slowing the threat of antibiotic resistance. Unfortunately, too few antibiotics are in development today, and no new classes of antibiotics used in patients have been discovered since 1987. As a result, Pew has also committed to working with experts to identify the key scientific challenges that pose obstacles to antibiotic discovery efforts and develop a roadmap for overcoming them.

We appreciate the White House’s leadership on antibiotic resistance, and look forward to working with the CDC and other stakeholders on this critical public health issue.

Learn more about Pew’s antibiotic resistance project.

The front facade of the Supreme Court of the United States in Washington, DC.

Agenda for America

A collection of resources to help federal, state, and local decision-makers set an achievable agenda for all Americans

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest. In the coming months, President Joe Biden and the 117th Congress will tackle a number of environmental, health, public safety, and fiscal and economic issues—nearly all of them complicated by the COVID-19 pandemic. To help solve specific, systemic problems in a nonpartisan fashion, Pew has compiled a series of briefings and recommendations based on our research, technical assistance, and advocacy work across America.


States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.

Allan Coukell
Antibiotic Resistance: Pressing Public Health Threat